REQUEST A DEMO
Total
USD $0.00
Search more companies

Gdi Pharma Centro S A S (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Gdi Pharma Centro S A S Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Gdi Pharma Centro S A S is a company based in Colombia, with its head office in Bogota D.C.. It operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on August 15, 2013. The total number of employees is currently 10 (2023). From the latest financial highlights, Gdi Pharma Centro S A S reported a net sales revenue drop of 15.63% in 2023. Its total assets grew by 3.39% over the same period. In 2023, Gdi Pharma Centro S A S’s net profit margin increased by 61.3%.

Headquarters
Cl 163 # 21 15
Bogota D.C.; Bogota D.C; Postal Code: 1023

Contact Details: Purchase the Gdi Pharma Centro S A S report to view the information.

Basic Information
Total Employees:
Purchase the Gdi Pharma Centro S A S report to view the information.
Outstanding Shares:
Purchase the Gdi Pharma Centro S A S report to view the information.
Incorporation Date:
August 15, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Gdi Pharma Centro S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-15.63%
Total operating revenue
-15.63%
Net Profit (Loss) for the Period
71.23%
Total assets
3.39%
Total equity
-24.1%
Net Profit Margin
61.3%
Return on Equity (ROE)
-64.35%
Quick Ratio
17.68%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?